Unbiased AI-powered news
Nexus NeuroTech Ventures, a venture capital fund focused on brain health with $200 million in assets, ceased operations on March 31, 2026. The firm, backed by Google co-founder Sergey Brin, is merging into his family office, Bayshore Global Management. The portfolio included 15 companies that supported over 200,000 individuals and 50 ongoing clinical studies.
BenzingaNexus NeuroTech Ventures shut down its operations as of March 31, 2026, Benzinga reported. The brain-health venture capital fund is in the process of being merged into Bayshore Global Management, according to Bloomberg as cited by Benzinga. The firm held $200 million in assets and had approximately 15 companies in its portfolio.
Nexus NeuroTech Ventures was backed by Google co-founder Sergey Brin. Brin supported the fund through his nonprofit Catalyst4. A 2024 tax filing indicated that Catalyst4 held roughly a 95% stake across multiple Nexus investment vehicles.
Companies in Nexus NeuroTech Ventures' portfolio have helped more than 200,000 individuals, Jordi Parramon stated. The portfolio includes 50+ ongoing clinical studies, Parramon added. Nexus NeuroTech Ventures was founded with a commitment to supporting solutions for neurodegenerative, neuropsychiatric, and neurodevelopmental conditions, according to Parramon.
"Through a recent acquisition, Nexus NeuroTech Ventures has concluded its operations," Parramon wrote in a post on LinkedIn. In addition, the body of clinical studies arising from this portfolio — currently 50+ ongoing studies — demonstrates the strong pipeline that has been created, providing a rigorous scientific foundation that has already yielded significant breakthroughs," he stated.
Parramon wrote a post on LinkedIn about the shutdown.
Sergey Brin is the world's fourth-richest individual with a net worth of $269 billion, according to the Bloomberg Billionaires Index as cited by Benzinga. Brin has spent decades supporting brain research. 75 billion toward advancing understanding of Parkinson's disease, according to Forbes as cited by Benzinga.
Sergey Brin's contributions to Parkinson's research are driven by his own genetic risk mutation and his mother’s diagnosis, Benzinga reported. Sergey Brin has invested in studies for autism and bipolar disorder. The Google co-founder has focused his philanthropy on brain research, including Parkinson's disease as a central area.
TankerTrackers data shows 36 million barrels shipped and another 36 million still at sea. Iranian officials separately reported 25 million barrels crossing the blockade line since Monday.
ForbesUFC CEO Dana White stated that negotiations for a cage fight between Elon Musk and Mark Zuckerberg were genuine and included discussions about holding the event at Rome's Colosseum. White said the venue requested an estimated $150 million, which would have gone toward restoring o…
winnipegfreepress.comProtesters gathered in front of Czech public television offices one day before staff planned a warning strike. The government approved the overhaul on Monday.